Genetic Technologies Ltd represents a commitment to genetic research and innovation in the field of personalized medicine. The company's core values include integrity, scientific excellence, and a strong focus on patient care. With a vision to enhance healthcare outcomes through genetic testing, Genetic Technologies aims to provide cutting-edge solutions to assist healthcare providers and empower individuals in making informed decisions about their health. By leveraging advanced technologies and partnerships, Genetic Technologies demonstrates a corporate philosophy centered on driving advancements in genomics and improving the quality of global healthcare.

Genetic Technologies Ltd is primarily present in Australia, where it is headquartered. The company operates in multiple regions within Australia, including Victoria and Queensland. As a global provider of molecular risk assessment tools, Genetic Technologies also has a presence in the United States. With an aim to improve healthcare through innovative genetic testing solutions, Genetic Technologies Ltd continues to expand its reach and strive for advancements in the field of genomics.

Genetic Technologies Ltd, a leading biotechnology company, has achieved numerous significant milestones throughout its journey. The company has successfully developed innovative genetic testing solutions, positioning itself as a pioneer in the field. Genetic Technologies Ltd has gained recognition for its breakthrough research and development, resulting in the development of commercially viable products. Additionally, the company has formed strategic partnerships, expanding its reach and enhancing its market presence. With its dedication to advancing genetic technologies, Genetic Technologies Ltd has secured valuable patents and intellectual property rights, further solidifying its position as a key player in the industry. Overall, Genetic Technologies Ltd has a proven track record of accomplishments, making it a compelling choice for investors seeking growth opportunities in the biotech sector.

Genetic Technologies Ltd is a renowned biotechnology company specializing in genetic testing and analysis. Established in 1989, the company has a rich history of over three decades in the field. Genetic Technologies has emerged as a leader in developing and commercializing innovative gene-based solutions for various industries, including healthcare, agriculture, and forensic sciences. With a strong focus on genetic research, the company has garnered international recognition for its expertise in DNA analysis, genotyping, and molecular diagnostics. Genetic Technologies Ltd continues to pioneer advancements in genetic science, empowering individuals and businesses with valuable genetic insights and solutions.

The main competitors of Genetic Technologies Ltd in the market include companies such as Myriad Genetics Inc., Quest Diagnostics Incorporated, and Illumina Inc. These companies operate within the genetic testing and diagnostics industry, offering similar products and services. However, Genetic Technologies Ltd distinguishes itself by leveraging its innovative technology and expertise to provide unique solutions in the field of genetic testing. As a leading player in this market, Genetic Technologies Ltd continuously strives to maintain its competitive edge through research and development, strategic partnerships, and expanding its product portfolio to cater to the growing demands and challenges of the industry.

Genetic Technologies Ltd is primarily active in the biotechnology and healthcare industries.

The business model of Genetic Technologies Ltd revolves around genetic analysis and testing services. The company specializes in developing and commercializing genetic risk assessment tools for various diseases and conditions. Genetic Technologies uses advanced genetic screening and analysis techniques to assess an individual's predisposition or susceptibility to certain diseases, thereby aiding in personalized healthcare and preventive medicine. By leveraging its proprietary technologies and intellectual property, Genetic Technologies aims to provide valuable genetic insights and solutions to healthcare providers, insurance companies, and individuals worldwide.

KGV za Genetic Technologies trenutno ne može biti izračunato.

KUV za Genetic Technologies trenutno ne može biti izračunat.

AlleAktien kvalitativni skor za Genetic Technologies je 6/10.

Prihod trenutno ne može biti izračunat za Genetic Technologies.

Profit trenutno ne može biti izračunat za Genetic Technologies.

Genetic Technologies Ltd is an international company specializing in the development of genetic tests and diagnostic kits. It was founded in 1989 and is headquartered in Melbourne, Australia. The company has become a leading provider in personalized medicine and genetic analysis. They offer a wide range of genetic tests for various conditions such as cancer, cardiovascular diseases, osteoporosis, and neurological disorders. They also provide diagnostic kits that are easy to use and provide quick results, making the treatment process easier for patients. Additionally, they engage in research and development to expand their portfolio of medical solutions. The company holds patents in the field of genetic analysis and licenses its technologies to other organizations. Some of their products include BRCA tests for identifying genetic mutations associated with breast and ovarian cancer, BREVAGenplus for assessing an individual's risk of developing breast cancer, CardioID for determining a person's risk of cardiovascular diseases, and COVID-19 tests for diagnosing coronavirus infections. With their innovative solutions in personalized medicine and genetic analysis, Genetic Technologies Ltd continuously expands its existing business areas and actively seeks new opportunities.

Genetic Technologies isplaćuje dividendu od 0 AUD raspoređenu preko isplata u toku godine.

Dividenda za Genetic Technologies trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Genetic Technologies je AU000000GTG7.

WKN od Genetic Technologies je 893882.

Oznaka za praćenje akcija kompanije Genetic Technologies je GTG.AX.

U poslednjih 12 meseci, Genetic Technologies je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Genetic Technologies će verovatno isplatiti dividendu od 0 AUD.

Dividendski prinos od Genetic Technologies trenutno iznosi .

Genetic Technologies isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Genetic Technologies je isplaćivao dividendu svake godine u poslednjih 0 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 0 AUD. To odgovara dividendnom prinosu od 0 %.

Genetic Technologies se svrstava u sektor 'Zdravlje'.

Da biste primili poslednju dividendu od Genetic Technologies od 7. 9. 2024. u iznosu od 0 AUD, morali ste da imate akciju u depou pre Ex-dana 7. 9. 2024..

Isplata poslednje dividende izvršena je 7. 9. 2024..

U godini 2023 kompanija Genetic Technologies je isplatila 0 AUD kao dividende.

Dividende od Genetic Technologies se isplaćuju u AUD.